Publication Information

{'id': 'https://openalex.org/W1980168719', 'doi': 'https://doi.org/10.1111/bjh.13004', 'title': 'Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma', 'display_name': 'Long‐term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma', 'publication_year': 2014, 'publication_date': '2014-06-30', 'ids': {'openalex': 'https://openalex.org/W1980168719', 'doi': 'https://doi.org/10.1111/bjh.13004', 'mag': '1980168719', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24974945'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13004', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13004', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'letter', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13004', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027394636', 'display_name': 'Craig B. Reeder', 'orcid': 'https://orcid.org/0000-0002-7158-0669'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Craig B. Reeder', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043490010', 'display_name': 'Donna Reece', 'orcid': 'https://orcid.org/0009-0002-9686-4323'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Donna E. Reece', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067291402', 'display_name': 'Vishal Kukreti', 'orcid': 'https://orcid.org/0000-0002-1681-3837'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Vishal Kukreti', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058598134', 'display_name': 'Joseph Mıkhael', 'orcid': 'https://orcid.org/0000-0001-9670-2864'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joseph R. Mikhael', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100606250', 'display_name': 'Christine Chen', 'orcid': 'https://orcid.org/0000-0002-9528-3669'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Christine Chen', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082712392', 'display_name': 'Suzanne Trudel', 'orcid': 'https://orcid.org/0000-0001-7952-6352'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Suzanne Trudel', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054336817', 'display_name': 'Kristina Laumann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5388228', 'display_name': 'University of Rochester', 'ror': 'https://ror.org/022kthw22', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I5388228']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kristina Laumann', 'raw_affiliation_strings': ['Mayo Cancer Center Statistics; Rochester MN USA'], 'affiliations': [{'raw_affiliation_string': 'Mayo Cancer Center Statistics; Rochester MN USA', 'institution_ids': ['https://openalex.org/I5388228']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033716003', 'display_name': 'Harjot Vohra', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Harjot Vohra', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5003015868', 'display_name': 'Rafaël Fonseca', 'orcid': 'https://orcid.org/0000-0002-5938-3769'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rafael Fonseca', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004436275', 'display_name': 'P. Leif Bergsagel', 'orcid': 'https://orcid.org/0000-0003-1523-7388'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'P. Leif Bergsagel', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112062579', 'display_name': 'José F. Leis', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jose F. Leis', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045418082', 'display_name': 'Rodger E. Tiedemann', 'orcid': 'https://orcid.org/0000-0003-1743-8810'}, 'institutions': [{'id': 'https://openalex.org/I2802654988', 'display_name': 'Princess Margaret Cancer Centre', 'ror': 'https://ror.org/03zayce58', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1325899441', 'https://openalex.org/I2802654988']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Rodger Tiedemann', 'raw_affiliation_strings': ['Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada'], 'affiliations': [{'raw_affiliation_string': 'Hematology/Oncology, Princess Margaret Hospital, Toronto, ON, Canada', 'institution_ids': ['https://openalex.org/I2802654988']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109667106', 'display_name': 'A. Keith Stewart', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. Keith Stewart', 'raw_affiliation_strings': ['Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA'], 'affiliations': [{'raw_affiliation_string': 'Hematology-Oncology, Mayo Clinic, Scottsdale, AZ, USA', 'institution_ids': ['https://openalex.org/I4210125099']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': None, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 40, 'citation_normalized_percentile': {'value': 0.937431, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '167', 'issue': '4', 'first_page': '563', 'last_page': '565'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9957, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.829912}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.7540435}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.75304973}, {'id': 'https://openalex.org/C2780401358', 'wikidata': 'https://www.wikidata.org/wiki/Q422252', 'display_name': 'Dexamethasone', 'level': 2, 'score': 0.7501484}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.7212534}, {'id': 'https://openalex.org/C2991767035', 'wikidata': 'https://www.wikidata.org/wiki/Q179661', 'display_name': 'Induction therapy', 'level': 3, 'score': 0.58976597}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5758314}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5273952}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.35730338}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': True}, {'descriptor_ui': 'D000293', 'descriptor_name': 'Adolescent', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015996', 'descriptor_name': 'Survival Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13004', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13004', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24974945', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.13004', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.13004', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.66, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 11, 'referenced_works': ['https://openalex.org/W1520916227', 'https://openalex.org/W1969648097', 'https://openalex.org/W1991660588', 'https://openalex.org/W2013123944', 'https://openalex.org/W2013370486', 'https://openalex.org/W2015003025', 'https://openalex.org/W2017412145', 'https://openalex.org/W2066800926', 'https://openalex.org/W2068889400', 'https://openalex.org/W2090310344', 'https://openalex.org/W4252667026'], 'related_works': ['https://openalex.org/W3029266790', 'https://openalex.org/W3028919400', 'https://openalex.org/W2563047534', 'https://openalex.org/W2409439928', 'https://openalex.org/W2377458274', 'https://openalex.org/W2124503326', 'https://openalex.org/W2104965094', 'https://openalex.org/W2104706142', 'https://openalex.org/W2063424779', 'https://openalex.org/W2027348595'], 'abstract_inverted_index': {'The': [0, 383, 420, 519, 525, 710, 972, 1133], 'past': [1], 'two': [2, 711], 'decades': [3], 'have': [4, 42, 68, 644, 719, 856, 1136], 'seen': [5, 628], 'remarkable': [6], 'improvement': [7], 'in': [8, 40, 44, 118, 244, 263, 458, 492, 506, 578, 588, 607, 651, 731, 762, 778, 895, 914, 922, 959, 1020], 'the': [9, 63, 281, 350, 356, 388, 402, 451, 513, 516, 543, 550, 573, 589, 608, 681, 740, 744, 765, 773, 779, 836, 873, 898, 919, 925, 951, 1000, 1035, 1049, 1055, 1060, 1080, 1089], 'outcomes': [10, 786], 'for': [11, 82, 131, 252, 258, 424, 499, 542, 648, 678, 887, 934, 953, 977, 1079], 'patients': [12, 86, 134, 143, 184, 191, 197, 331, 426, 444, 466, 494, 552, 565, 581, 594, 633, 655, 832, 844, 853, 916, 927, 991], 'with': [13, 62, 149, 198, 432, 456, 485, 667, 700, 715, 727, 834, 846, 859, 967, 980], 'multiple': [14, 152], 'myeloma': [15, 203], '(MM)': [16], '(Kumar': [17, 787], 'et': [18, 36, 122, 323, 749, 753, 788, 824, 849], 'al,': [19, 37, 123, 324, 750, 754, 789, 825, 850], '2008).': [20], 'High': [21], 'dose': [22, 246, 251, 257], 'melphalan': [23], 'and': [24, 32, 53, 70, 94, 107, 115, 140, 157, 176, 187, 201, 208, 242, 272, 297, 317, 340, 398, 408, 455, 472, 510, 528, 538, 558, 656, 670, 695, 717, 724, 746, 797, 805, 890, 932, 938, 945, 1005, 1007, 1022, 1046, 1052, 1071, 1107, 1116, 1122, 1127, 1129], 'stem': [25, 301, 337, 935], 'cell': [26, 338, 936], 'transplantation': [27], '(SCT)': [28], 'has': [29, 685, 870, 1075, 1092, 1111], 'improved': [30, 69, 885], 'responses': [31, 72, 117, 560, 931], 'lengthened': [33], 'survival': [34, 288, 291, 666, 809, 838, 976], '(Harousseau': [35], '2009).': [38], 'Advances': [39], 'science': [41], 'ushered': [43], 'new': [45], 'classes': [46], 'of': [47, 58, 104, 147, 215, 294, 315, 349, 394, 416, 449, 464, 503, 515, 549, 599, 637, 660, 680, 713, 722, 729, 735, 743, 767, 802, 831, 876, 900, 911, 924, 984, 988, 1003, 1082, 1088, 1139], 'drugs': [48, 65, 643], 'including': [49], 'immunomodulatory': [50], 'agents': [51, 61], '(IMiDs)': [52], 'proteasome': [54], 'inhibitors': [55], '(PIs).': [56], 'Combinations': [57, 636], 'these': [59, 668, 821], 'novel': [60], 'alkylating': [64], '(melphalan,': [66], 'cyclophosphamide)': [67], 'deepened': [71], 'over': [73], 'single': [74], 'agent': [75], 'therapy.': [76, 189, 956], 'A': [77, 800], 'phase': [78, 212], '2': [79, 213, 253, 259, 473], 'clinical': [80], 'trial': [81, 214, 384, 1026], 'newly': [83, 150, 199, 652], 'diagnosed': [84, 151, 200, 653], 'MM': [85, 654, 978, 1021, 1083], 'was': [87, 280, 327, 345, 353, 361, 373, 385, 399, 413, 430, 453, 490, 511, 522, 576, 627, 839, 905, 1027], 'conducted': [88], 'at': [89, 138, 512, 582, 810, 994], 'Mayo': [90, 313, 403], 'Clinic': [91, 404], 'Arizona': [92], '(MCA)': [93], 'Princess': [95], 'Margaret': [96], 'Hospital,': [97], 'Toronto': [98], '(PMH),': [99], 'utilizing': [100], 'an': [101, 159, 193, 1009], 'induction': [102, 471, 649, 683, 793], 'regimen': [103, 869], 'cyclophosphamide,': [105], 'bortezomib': [106, 222, 694], 'dexamethasone': [108, 243, 696, 768, 798], '(CyBorD).': [109], 'This': [110, 948, 1025], 'triplet': [111, 671], 'combination': [112, 296, 794, 949], 'produced': [113], 'rapid': [114], 'deep': [116], 'previous': [119], 'studies': [120, 883], '(Reeder': [121], '2009,': [124], '2010).': [125], 'We': [126], 'report': [127], 'long-term': [128, 676], 'follow-up': [129, 677], 'data': [130], 'all': [132, 425, 446], '63': [133, 465, 551, 926], 'treated': [135, 833], 'on': [136, 210, 879, 999, 1085], 'CyBorD': [137, 783, 804, 847, 860, 929, 957, 997], 'MCA': [139], 'PMH.': [141], 'Eligible': [142], 'were': [144, 185, 204, 286, 304, 531, 553], '≥18': [145], 'years': [146], 'age': [148], 'myeloma,': [153], 'had': [154, 158, 474, 559, 595], 'measurable': [155], 'disease,': [156], 'Eastern': [160], 'Cooperative': [161], 'Oncology': [162], 'Group': [163], 'performance': [164], 'score': [165], '≤2,': [166], 'creatinine': [167], '<309·4': [168], 'μmol/l,': [169], 'absolute': [170], 'neutrophil': [171], 'count': [172, 178], '≥1': [173], '×': [174, 181], '109/l,': [175], 'platelet': [177], '≥': [179], '1': [180], '109/l.': [182], 'All': [183, 190, 1057], 'symptomatic': [186, 202], 'needed': [188], 'signed': [192], 'informed': [194], 'consent.': [195], 'Sixty-three': [196], 'enrolled': [205], 'between': [206], '2006': [207], '2008': [209], 'a': [211, 264, 273, 435, 459, 475, 500, 596, 613, 828, 960, 981, 1077], 'weekly': [216, 962], 'oral': [217], 'cyclophosphamide': [218, 707], '300': [219], 'mg/m2,': [220], 'IV': [221], '1·3': [223], 'mg/m2': [224, 234], 'days': [225, 235], '1,': [226, 236], '4,': [227], '8,': [228, 237], '11': [229], '(Cohort': [230, 240, 247, 261], '1)': [231, 248], 'or': [232, 249, 309, 381, 441, 461, 488, 640, 699, 706, 969], '1·5': [233], '15,': [238], '22': [239], '2)': [241, 262], 'high': [245, 250, 307, 501, 555, 579], 'cycles,': [254], 'then': [255], 'low': [256], 'cycles': [260, 279, 448], '28': [265], 'day': [266], 'cycle.': [267], 'Patients': [268, 303], 'received': [269, 1076, 1093], 'prophylactic': [270], 'acyclovir': [271], 'quinolone': [274], 'antibiotic.': [275], 'Response': [276], 'after': [277, 336, 343, 470, 478], '4': [278, 447, 642], 'primary': [282], 'goal.': [283], 'Secondary': [284], 'goals': [285], 'progression-free': [287], '(PFS),': [289], 'overall': [290, 421], '(OS),': [292], 'toxicity': [293], 'this': [295], 'ability': [298], 'to': [299, 306, 334, 367, 379, 497, 562, 630, 687, 739, 760, 842, 855, 918], 'harvest': [300], 'cells.': [302], 'stratified': [305], 'risk': [308, 311, 502, 556, 564, 580, 591, 610, 632, 990], 'standard': [310, 563, 590, 609, 631, 989], 'by': [312, 387, 401, 1029], 'Stratification': [314], 'Myeloma': [316], 'Risk-Adapted': [318], 'Therapy': [319], '(mSMART)': [320], 'criteria': [321], '(Dispenzieri': [322], '2007).': [325], 'It': [326], 'assumed': [328], 'that': [329, 763, 1012], 'most': [330], 'would': [332], 'proceed': [333], 'SCT': [335, 344, 469, 477], 'collection': [339, 937], 'no': [341, 816, 868, 1137], 'maintenance': [342], 'planned': [346], 'as': [347, 363, 375, 415, 733, 771, 1017], 'part': [348, 734], 'trial.': [351], 'Survival': [352], 'calculated': [354], 'using': [355], 'Kaplan': [357], 'Meier': [358], 'method.': [359], 'OS': [360, 529, 615, 983], 'defined': [362, 374], 'time': [364, 376, 899], 'from': [365, 369, 377, 1031, 1068, 1096, 1114, 1125, 1131], 'registration': [366, 378], 'death': [368], 'any': [370], 'cause.': [371], 'PFS': [372, 521, 527, 575, 598, 858, 886], 'progression': [380], 'death.': [382], 'approved': [386, 1059], 'institutional': [389], 'review': [390], 'board/research': [391], 'ethics': [392], 'board': [393], 'both': [395, 732, 764, 1014], 'treating': [396, 517], 'centres': [397], 'monitored': [400], 'Cancer': [405], 'Center': [406], 'Data': [407, 412], 'Safety': [409], 'Monitoring': [410], 'Board.': [411], 'frozen': [414], '26': [417], 'February,': [418], '2014.': [419], 'response': [422, 439, 944], '(ORR)': [423], '(n': [427], '=': [428, 570, 625], '63)': [429], '89%': [431], '62%': [433], 'achieving': [434], 'very': [436], 'good': [437], 'partial': [438], '(VGPR)': [440], 'better.': [442, 462], 'For': [443], 'completing': [445], 'therapy': [450, 480, 484, 650, 904, 921, 1019], 'ORR': [452, 721], '93%': [454], '67%': [457], 'VGPR': [460, 728], 'Forty-nine': [463], 'underwent': [467], 'autologous': [468], 'subsequent': [476], 'additional': [479, 920], '(51/63,': [481], '81%).': [482], 'Maintenance': [483], 'either': [486, 701], 'lenalidomide': [487, 702, 796], 'thalidomide': [489, 704], 'administered': [491], '18': [493, 923], '(29%)': [495], 'due': [496], 'concern': [498, 910], 'early': [504, 912], 'relapse': [505, 913], 'cytogenetic': [507], 'high-risk': [508, 915], 'patients,': [509, 979], 'discretion': [514], 'physician.': [518], 'median': [520, 574], '40·0': [523], 'months.': [524], '5-year': [526, 597, 837, 982], 'rates': [530], '42%': [532], '(95%': [533], 'confidence': [534], 'interval': [535], '[CI]:': [536], '31–57)': [537], '70%': [539], '(95%CI:': [540, 601, 605, 618, 622], '59–82)': [541], 'entire': [544], 'group': [545], '(Fig': [546, 634], '1).': [547], 'Twenty-four': [548], 'considered': [554], '(38%)': [557], 'equal': [561], '(88%': [566], 'vs.': [567, 585, 603, 620, 864], '90%,': [568], 'P': [569], '1·0)': [571], 'However,': [572], 'shorter': [577], '27·6': [583], 'months': [584, 587], '55·7': [586], 'patients.': [592], 'High-risk': [593, 852], '33%': [600], '19–59)': [602], '48%': [604], '33–69)': [606], 'group.': [611], 'Likewise': [612], 'lower': [614], 'rate': [616], '(54%': [617], '37–78)': [619], '81%': [621], '69–95))': [623], '(P': [624], '0·04)': [626], 'compared': [629], '2).': [635], '2,': [638], '3': [639, 811], 'even': [641, 892], 'become': [645], 'common': [646, 792], 'practice': [647, 908], 'can': [657, 941], 'produce': [658], 'ORRs': [659], '≥90%.': [661], 'Short': [662], 'term': [663], '(1–2': [664], 'years)': [665, 866], 'doublet': [669], 'treatments': [672], 'is': [673, 758, 769, 772, 776, 795, 964, 974, 1008, 1013], 'excellent,': [674], 'but': [675, 813], 'many': [679], 'newer': [682], 'regimens': [684, 692, 822], 'yet': [686], 'be': [688], 'reported.': [689], 'Commonly': [690], 'used': [691], 'employ': [693], 'alone': [697], '(VD),': [698], '(VRD),': [703], '(VTD)': [705], '(CyBorD,': [708], 'VCD).': [709], 'platforms': [712], 'carfilzomib': [714], 'RD': [716, 862], 'RVD': [718, 757], 'generated': [720], '98%': [723], '100%,': [725], 'respectively,': [726], '75%': [730], 'prospective': [736, 817], 'studies,': [737], 'pointing': [738], 'potent': [741], 'synergy': [742, 1002], 'PIs': [745, 1004], 'IMiDs': [747], '(Richardson': [748], '2010;': [751], 'Jakubowiak': [752], '2012).': [755, 790, 826], 'Whilst': [756], 'different': [759, 770], 'VRD': [761, 781], 'schedule': [766, 963], 'dose,': [774], 'which': [775, 940], 'less': [777], 'latter,': [780], 'versus': [782], 'showed': [784, 807], 'similar': [785, 808, 841], 'Another': [791], '(RD).': [799], 'comparison': [801], 'RD,': [803, 835], 'CRD': [806], 'years,': [812], 'there': [814], 'are': [815, 992], 'randomized': [818], 'trials': [819], 'comparing': [820], '(Khan': [823], 'In': [827], 'recent': [829, 882], 'analysis': [830], '71%,': [840], 'our': [843, 901], 'teated': [845], '(Srivastava': [848], '2013).': [851], 'appear': [854], 'better': [857], 'than': [861], '(2·3': [863], '1·7': [865], 'though': [867], 'totally': [871], 'eliminated': [872], 'deleterious': [874], 'impact': [875], 'adverse': [877], 'cytogenetics': [878], 'OS.': [880, 896], 'Several': [881], 'show': [884], 'post-SCT': [888], 'treatment': [889], 'one': [891], 'suggests': [893], 'benefit': [894], 'At': [897], 'trial,': [902], 'post-transplant': [903], 'not': [906, 965], 'routine': [907], 'although': [909], 'led': [917], '(29%).': [928], 'maximizes': [930], 'allows': [933], 'transplantation,': [939], 'further': [942], 'consolidate': [943], 'improve': [946], 'outcome.': [947], 'preserves': [950], 'opportunity': [952], 'future': [954], 'IMiD': [955, 1023], 'employed': [958], 'once': [961], 'associated': [966], 'thrombosis': [968], 'severe': [970], 'neuropathy.': [971], 'result': [973], 'excellent': [975], '70%.': [985], 'Eighty-one': [986], 'percent': [987], 'alive': [993], '5': [995], 'years.': [996], 'builds': [998], 'preclinical': [1001], 'alkylation': [1006], 'important': [1010], 'option': [1011], 'highly': [1015], 'active': [1016], 'initial': [1018], 'sparing.': [1024], 'funded': [1028], 'support': [1030], 'Millennium.': [1032, 1072], 'CBR': [1033], 'wrote': [1034], 'paper.': [1036, 1050, 1062], 'DER,': [1037], 'VK,': [1038], 'JRM,': [1039], 'CC,': [1040], 'ST,': [1041], 'RF,': [1042], 'PLB,': [1043], 'JFL,': [1044], 'RT': [1045], 'AKS': [1047], 'revised': [1048], 'KL': [1051], 'HV': [1053], 'analysed': [1054], 'data.': [1056], 'authors': [1058, 1135], 'final': [1061], 'Dr.': [1063, 1118], 'Reeder': [1064], 'receives': [1065, 1120], 'research': [1066, 1113, 1123], 'funding': [1067, 1124], 'Novartis,': [1069], 'Celgene': [1070], 'Dr': [1073], 'Fonseca': [1074], 'patent': [1078], 'prognostication': [1081], 'based': [1084], 'genetic': [1086], 'categorization': [1087], 'disease.': [1090], 'He': [1091, 1109], 'consulting': [1094], 'fees': [1095], 'Medtronic,': [1097], 'Otsuka,': [1098], 'Celgene,': [1099], 'Genzyme,': [1100], 'BMS,': [1101], 'Lilly,': [1102], 'Onyx,': [1103], 'Binding': [1104], 'Site,': [1105], 'Millennium': [1106, 1126], 'AMGEN.': [1108], 'also': [1110], 'sponsored': [1112], 'Cylene': [1115], 'Onyx.': [1117], 'Stewart': [1119], 'honoraria': [1121, 1130], 'Onyx': [1128], 'Celgene.': [1132], 'remaining': [1134], 'conflicts': [1138], 'interest.': [1140]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1980168719', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 6}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 7}, {'year': 2017, 'cited_by_count': 7}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 3}], 'updated_date': '2024-12-09T08:08:24.666396', 'created_date': '2016-06-24'}